Hyperuricemia Micromolecular Drugs Market Analysis Report: History and Forecast 2026
The global market for Hyperuricemia Micromolecular Drugs was estimated to be worth US$ 2934 million in 2024 and is forecast to a readjusted size of US$ 5219 million by 2031 with a CAGR of 8.7% during…
公開 : 2026/02/02 16:58